B-Cell Proliferation of Uncertain Malignant Potential

B-Cell Proliferation of Uncertain Malignant Potential — Trials · CancerIndex

Clinical trials

Registered studies

83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–58 of 58 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00101270	Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas	completed	Phase 1	24	National Cancer Institute (NCI)NIH	1	Jun 5, 2013	clinicaltrials
NCT00054483	Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction	completed	Phase 1	69	National Cancer Institute (NCI)NIH	1	May 16, 2013	clinicaltrials
NCT00348985	PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas	completed	Phase 1	55	National Cancer Institute (NCI)NIH	1	May 3, 2013	clinicaltrials
NCT00098891	MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

Data updated 23 days agoSource updated Jun 5, 2013source: clinicaltrials